Integrated HIV/AIDS Program (IHAP)

Funding Agency:
US Agency for International Development

The U.S. Agency for International Development’s (USAID) Democratic Republic of Congo (DRC) Mission (USAID/DRC) seeks applications for funding that will assist one or more recipients to carry out the five-year Integrated HIV/AIDS Program (IHAP), which intends to work with the Government of the DRC (GDRC) to strengthen the continuum of care1 for quality HIV/AIDS services in select health zones to achieve epidemic control. This will be one of the main implementing mechanisms for the President’s Emergency Plan for AIDS Relief (PEPFAR) in the DRC. 

Under IHAP, USAID expects to award two cooperative agreements–one assisting a recipient to carry out its program that improves service delivery and provides technical assistance to health zones in Kinshasa and central-level government institutions (referred to as IHAP-Kinshasa award) and a second award assisting a recipient to carry out its program improving service delivery and providing technical assistance to health zones in Haut-Katanga and Lualaba provinces2 (referred to as IHAP-Katanga award). USAID is committed to fund two agreements, up to $70 million combined, over the five-year period (subject to availability of funds) to cover activities in the applicant’s Program Description. The total funding amount will be contingent on number of health zones covered, burden of need, existing infrastructure, and activities required to achieve scale-up. USAID intends that both agreements should include interventions at the provincial, health zone, facility, and community levels. The majority of funding will be from the USAID/DRC Health Program’s HIV/AIDS funds provided through PEPFAR.

USAID intends that the recipient’s activities align with the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90, an ambitious treatment target to help end the AIDS epidemic by ensuring that by 2020, 90 percent of all people living with HIV know their HIV status, 90 percent of all people with diagnosed HIV infection receive sustained antiretroviral therapy (ART), and 90 percent of people receiving ART have viral suppression. As a result, USAID will finance the recipient’s activities that scale up HIV/AIDS services in focus health zones, including prevention; HIV testing services (HTS) in high yield entry points; enrollment in care and support services for HIV-positive clients; treatment of HIV-positive clients who are eligible; and retention of clients on treatment. USAID seeks to finance activities that also strengthen HIV/Tuberculosis (TB) integration and family planning (FP) activities.

Deadline: Sep. 1, 2016

Agency Website

Eligibility Requirements

This NOFO is a full and open competition with no eligibility restrictions. Any types of U.S. and non-U.S. organizations may participate under this NOFO. 

Amount Description

Subject to funding availability, USAID intends to provide $70 million in total USAID funding over a five year period. The ceiling for this program is $70 million for two awards. Actual funding amounts are subject to availability of funds. USAID intends to award two (2) Cooperative Agreements pursuant to this notice of funding opportunity. The Haut Katanga/Lualaba Cooperative Agreement will be approximately 65 percent of the total ceiling and the Kinshasa Cooperative Agreement will be approximately 35 percent of the total ceiling. 

Funding Type





International Opportunities
Medical - Basic Science
Medical - Clinical Science
Social Sciences

External Deadline

September 1, 2016